Global Ophthalmology AI Screening Software Market Strategic Research Report

Scope of the Report

The global Ophthalmology AI Screening Software market size is predicted to grow from US$ 1,988 million in 2025 to US$ 11,624 million in 2032; it is expected to grow at a CAGR of 29.3% from 2026 to 2032.

Ophthalmic AI screening software is an artificial intelligence software used in the field of ophthalmic disease screening. It is based on deep learning algorithms and realizes automatic screening, auxiliary diagnosis and condition assessment of ophthalmic diseases by analyzing ophthalmic related data such as fundus images.

The prospects for ophthalmic AI screening software are broad, and it is currently at a critical stage of evolution from "single-disease-assisted detection" to "comprehensive multi-disease assessment and systemic health early warning." The market growth drivers are clear: the increase in the global diabetic patient population and the aging population has driven up the rigid demand for early eye disease screening; continuous progress in deep learning technology has improved the accuracy and reliability of algorithms; at the same time, supportive regulatory policies and exploration of medical insurance payment are accelerating its clinical implementation. In the future, this field will exhibit three major trends: First, technological integration, which will be combined with portable devices and telemedicine platforms to expand screening scenarios from hospitals to grassroots communities and even homes; second, functional diversification, extending from single eye disease screening to predicting disease progression and assessing overall health; and third, ecosystem systematization, integrating into the closed loop of "prevention-screening-diagnosis-management" and becoming an important digital infrastructure for eye health and even chronic disease management systems.

This report presents a comprehensive overview of the global Ophthalmology AI Screening Software market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• On-premises
• Cloud-based

Segment by Technology/Imaging Fundamentals

• AI Based on Fundus Images
• AI Based on OCT

Segment by Core Functions

• Disease Screening and Assisted Diagnosis Software
• Systemic Health Risk Assessment Software

Segment by Application

• Hospital
• Eye Clinic
• Medical Research
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Ophthalmology AI Screening Software market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Eye Clinic, Medical Research evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact